420 related articles for article (PubMed ID: 34873286)
1. Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective.
Halawa S; Pullamsetti SS; Bangham CRM; Stenmark KR; Dorfmüller P; Frid MG; Butrous G; Morrell NW; de Jesus Perez VA; Stuart DI; O'Gallagher K; Shah AM; Aguib Y; Yacoub MH
Nat Rev Cardiol; 2022 May; 19(5):314-331. PubMed ID: 34873286
[TBL] [Abstract][Full Text] [Related]
2. From acute SARS-CoV-2 infection to pulmonary hypertension.
Eroume À Egom E; Shiwani HA; Nouthe B
Front Physiol; 2022; 13():1023758. PubMed ID: 36601347
[TBL] [Abstract][Full Text] [Related]
3. COVID-19: a conundrum to decipher.
Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
[TBL] [Abstract][Full Text] [Related]
4. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
[TBL] [Abstract][Full Text] [Related]
5. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Respiratory and Neurological Sequelae of COVID-19.
Wang F; Kream RM; Stefano GB
Med Sci Monit; 2020 Nov; 26():e928996. PubMed ID: 33177481
[TBL] [Abstract][Full Text] [Related]
7. Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection.
Mylvaganam RJ; Bailey JI; Sznajder JI; Sala MA;
Eur Respir Rev; 2021 Dec; 30(162):. PubMed ID: 34911696
[TBL] [Abstract][Full Text] [Related]
8. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
Elife; 2020 Apr; 9():. PubMed ID: 32338605
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk between SARS-CoV-2 Infection and Neurological Disorders: A Review.
Azhar A; Wali MA; Rashid Q; Khan WH; Al-Hosaini K; Owais M; Kamal MA
CNS Neurol Disord Drug Targets; 2023; 22(5):643-658. PubMed ID: 35440321
[TBL] [Abstract][Full Text] [Related]
10. Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany.
Edler C; Schröder AS; Aepfelbacher M; Fitzek A; Heinemann A; Heinrich F; Klein A; Langenwalder F; Lütgehetmann M; Meißner K; Püschel K; Schädler J; Steurer S; Mushumba H; Sperhake JP
Int J Legal Med; 2020 Jul; 134(4):1275-1284. PubMed ID: 32500199
[TBL] [Abstract][Full Text] [Related]
11. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
[TBL] [Abstract][Full Text] [Related]
12. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 and the lungs: A review.
Su WL; Lu KC; Chan CY; Chao YC
J Infect Public Health; 2021 Nov; 14(11):1708-1714. PubMed ID: 34700289
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.
Anand P; Puranik A; Aravamudan M; Venkatakrishnan AJ; Soundararajan V
Elife; 2020 May; 9():. PubMed ID: 32452762
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective.
Hosoki K; Chakraborty A; Sur S
J Allergy Clin Immunol; 2020 Aug; 146(2):285-299. PubMed ID: 32624257
[TBL] [Abstract][Full Text] [Related]
16. At a crossroads: coronavirus disease 2019 recovery and the risk of pulmonary vascular disease.
Cascino TM; Desai AA; Kanthi Y
Curr Opin Pulm Med; 2021 Sep; 27(5):342-349. PubMed ID: 34127622
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary Hypertensive Changes Secondary to COVID-19 Pneumonia in a Chronically SARS-CoV-2-Infected Bilateral Lung Explant.
Rohr JM; Strah H; Berkheim D; Siddique A; Radio SJ; Swanson BJ
Int J Surg Pathol; 2022 Jun; 30(4):443-447. PubMed ID: 34894817
[TBL] [Abstract][Full Text] [Related]
18. Single-cell RNA analysis on ACE2 expression provides insights into SARS-CoV-2 potential entry into the bloodstream and heart injury.
Guo J; Wei X; Li Q; Li L; Yang Z; Shi Y; Qin Y; Zhang X; Wang X; Zhi X; Meng D
J Cell Physiol; 2020 Dec; 235(12):9884-9894. PubMed ID: 32510598
[TBL] [Abstract][Full Text] [Related]
19. Advances in Pathogenesis, Progression, Potential Targets and Targeted Therapeutic Strategies in SARS-CoV-2-Induced COVID-19.
Zhou H; Ni WJ; Huang W; Wang Z; Cai M; Sun YC
Front Immunol; 2022; 13():834942. PubMed ID: 35450063
[TBL] [Abstract][Full Text] [Related]
20. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]